WUXI XDC: WuXi AppTec (Shanghai) Pharmaceutical R&D Co., Ltd. Disposes of Shares, Long Position Falls to 14.14%

HK Disclosure

09/04

WuXi AppTec (Shanghai) Pharmaceutical R&D Co., Ltd. sold 53.52 million shares of WUXI XDC (02268) stock at an average of HKD 73.23 per share on August 31, 2026, involving about HKD 3.92 billion.

Prior to the disposal, WuXi AppTec (Shanghai) Pharmaceutical R&D Co., Ltd.'s long position in WUXI XDC was 232.90 million shares, representing 18.36%; following the disposal, the holding changed to 179.38 million shares, with the long position ratio falling to 14.14%.

Source: Hong Kong Exchanges and Clearing Limited.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1168517935"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1168517935\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1168517935?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-04 17:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1168517935","market":"hk","top_or_hot":-1,"title":"WUXI XDC: WuXi AppTec (Shanghai) Pharmaceutical R&D Co., Ltd. Disposes of Shares, Long Position Falls to 14.14%","media":"HK Disclosure","content":"<p><p>WuXi AppTec (Shanghai) Pharmaceutical R&D Co., Ltd. sold 53.52 million shares of WUXI XDC (02268) stock at an average of HKD 73.23 per share on August 31, 2026, involving about HKD 3.92 billion.</p><p>Prior to the disposal, WuXi AppTec (Shanghai) Pharmaceutical R&D Co., Ltd.'s long position in WUXI XDC was 232.90 million shares, representing 18.36%; following the disposal, the holding changed to 179.38 million shares, with the long position ratio falling to 14.14%.</p><p>Source: <a href=\"https://sc.hkexnews.hk/TuniS/di.hkex.com.hk/di/NSForm2.aspx?fn=CS20260903E00583&sa2=ns&sid=449799&sd=04/09/2025&ed=04/09/2026&sa1=cl&scsd=04/09/2025&sced=04/09/2026&sc=02268&src=Main&lang=ZH&tk=ds\" target=\"_blank\">Hong Kong Exchanges and Clearing Limited</a>.</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WUXI XDC: WuXi AppTec (Shanghai) Pharmaceutical R&D Co., Ltd. Disposes of Shares, Long Position Falls to 14.14%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWUXI XDC: WuXi AppTec (Shanghai) Pharmaceutical R&D Co., Ltd. Disposes of Shares, Long Position Falls to 14.14%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1069314323\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/a632f2fd508536f86d1ef761a603574c);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">HK Disclosure </p>\n<p class=\"h-time\">2026-09-04 17:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>WuXi AppTec (Shanghai) Pharmaceutical R&D Co., Ltd. sold 53.52 million shares of WUXI XDC (02268) stock at an average of HKD 73.23 per share on August 31, 2026, involving about HKD 3.92 billion.</p><p>Prior to the disposal, WuXi AppTec (Shanghai) Pharmaceutical R&D Co., Ltd.'s long position in WUXI XDC was 232.90 million shares, representing 18.36%; following the disposal, the holding changed to 179.38 million shares, with the long position ratio falling to 14.14%.</p><p>Source: <a href=\"https://sc.hkexnews.hk/TuniS/di.hkex.com.hk/di/NSForm2.aspx?fn=CS20260903E00583&sa2=ns&sid=449799&sd=04/09/2025&ed=04/09/2026&sa1=cl&scsd=04/09/2025&sced=04/09/2026&sc=02268&src=Main&lang=ZH&tk=ds\" target=\"_blank\">Hong Kong Exchanges and Clearing Limited</a>.</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02268","symbol_name":"药明合联","start_time":0,"source_url":"","article_id":"1168517935","we_media_id":"1069314323","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1168517935","pubTimestamp":1788515481,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"HK Disclosure","introduction":"Provide the latest Hong Kong stock disclosure of interests.","home_visible":1,"id":"1069314323","head_image":"https://community-static.tradeup.com/news/a632f2fd508536f86d1ef761a603574c"},"summary":"WuXi AppTec (Shanghai) Pharmaceutical R&D Co., Ltd. sold 53.52 million shares of WUXI XDC (02268) stock at an average of HKD 73.23 per share on August 31, 2026, involving about HKD 3.92 billion.Prior...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02268":"药明合联"},"translate_title":"药明XDC：药明康德（上海）医药研发有限公司出售股份，多头头寸降至14.14%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02268":1},"content_text":"WuXi AppTec (Shanghai) Pharmaceutical R&D Co., Ltd. sold 53.52 million shares of WUXI XDC (02268) stock at an average of HKD 73.23 per share on August 31, 2026, involving about HKD 3.92 billion.Prior to the disposal, WuXi AppTec (Shanghai) Pharmaceutical R&D Co., Ltd.'s long position in WUXI XDC was 232.90 million shares, representing 18.36%; following the disposal, the holding changed to 179.38 million shares, with the long position ratio falling to 14.14%.Source: Hong Kong Exchanges and Clearing Limited.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}